Regeneron Pharmaceuticals Inc: Premium Company Profile

Publication Date	December 2007
Publisher	Datamonitor
Product Type	Databook
Pages	51
ISBN Number	not applicable
Product Code	DAT09432

Price

£265.00
approximately: $468 | €336

PRINT £265 ($468 | €336)

Order above formats by FAX

Summary

Introduction

Regeneron Pharmaceuticals is a biopharmaceutical company mainly focused on the development and commercialization of products for oncology, age-related macular degeneration (AMD), and autoimmune diseases. The company is developing its drugs using its Trap technology, which is designed to block key cytokine targets in order to treat disease.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Regeneron Pharmaceuticals discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.

The company derives all of its revenues from contract manufacturing, research and development payments from collaborators and licensing of products. Its total revenues increased at a CAGR of 30% during 2002-2006, from $22 million to $63 million.

Regeneron Pharmaceuticals's total revenues are forecast to increase at a CAGR of 57% from $51 million to $308 million during 2006-2010, representing an absolute growth of +$257 million. The increase in contract and collaborative revenues is due to the advancement of product candidates under collaborations with Bayer Healthcare and Sanofi-Aventis.

Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content

Overview
Catalyst
- Summary
- Company Structure
- Company Overview and Key Facts
- Business Description
- History
- Company Financials
- Stock Market Performance
- P&L
- Balance Sheet
- Cash Flow
- Business Segment Performance
- Products & Services
- Pipeline Products
- AC Forecast Product Sales
- Competitors and Strategic Business Relationships
- Key Competitors
- Key Suppliers
- Key Clients
- Shareholding Structure
- Strategy
- Company View
- Corporate Strategy
- SWOT Analysis
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Value Chain Analysis
- Overview
- Discovery and Product Development
- Manufacturing
- Scorecard
- Overview
- Scorecard Analysis
- Key Employees
- List of Key Employees
- Key Employee Biographies
- Financial and Operational Overview
- Financial and Operational Overview
Appendix
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- Figure 1: Regeneron Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 1: Regeneron Pharmaceuticals - Key Facts
- Table 2: Regeneron Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($)
- Table 3: Regeneron Pharmaceuticals - Key Events Impacting Share Price Performance
- Table 4: Regeneron Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
- Table 5: Regeneron Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
- Table 6: Regeneron Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn)
- Table 7: Regeneron Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn)
- Table 8: Regeneron Pharmaceuticals - Business Segment Performance, 2002-2006 ($ Mn)
- Table 9: Regeneron Pharmaceuticals - in-house Pipeline Products
- Table 10: Regeneron Pharmaceuticals - Collaboration Products
- Table 11: Regeneron Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn)
- Table 12: Regeneron Pharmaceuticals - Key Competitors
- Table 13: Regenoron Pharmaceuticals - Key Suppliers
- Table 14: Regenoron Pharmaceuticals - Key Clients
- Table 15: Regeneron Pharmaceuticals - Key Shareholders
- Table 16: Regeneron Pharmaceuticals - SWOT Analysis Summary
- Table 17: Regeneron Pharmaceuticals - Value Chain Analysis
- Table 18: Regeneron Pharmaceuticals - Scorecard
- Table 19: Regeneron Pharmaceuticals - Key Employees
- Table 20: Regeneron Pharmaceuticals - Financial and Operational Overview